Christie, J.D.; Appel, N.; Zhang, L.; Lowe, K.; Kilbourne, J.; Daggett-Vondras, J.; Elliott, N.; Lucas, A.R.; Blattman, J.N.; Rahman, M.M.;
et al. Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma. Cancers 2022, 14, 337.
https://doi.org/10.3390/cancers14020337
AMA Style
Christie JD, Appel N, Zhang L, Lowe K, Kilbourne J, Daggett-Vondras J, Elliott N, Lucas AR, Blattman JN, Rahman MM,
et al. Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma. Cancers. 2022; 14(2):337.
https://doi.org/10.3390/cancers14020337
Chicago/Turabian Style
Christie, John D., Nicole Appel, Liqiang Zhang, Kenneth Lowe, Jacquelyn Kilbourne, Juliane Daggett-Vondras, Natalie Elliott, Alexandra R. Lucas, Joseph N. Blattman, Masmudur M. Rahman,
and et al. 2022. "Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma" Cancers 14, no. 2: 337.
https://doi.org/10.3390/cancers14020337
APA Style
Christie, J. D., Appel, N., Zhang, L., Lowe, K., Kilbourne, J., Daggett-Vondras, J., Elliott, N., Lucas, A. R., Blattman, J. N., Rahman, M. M., & McFadden, G.
(2022). Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma. Cancers, 14(2), 337.
https://doi.org/10.3390/cancers14020337
